- Home
- ABL vs AVNS Comparison
ABL vs AVNS Comparison
Compare ABL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABL
- AVNS
- Stock Information
- Founded
- ABL 2004
- AVNS 2014
- Country
- ABL United States
- AVNS United States
- Employees
- ABL N/A
- AVNS N/A
- Industry
- ABL Investment Managers
- AVNS Industrial Specialties
- Sector
- ABL Finance
- AVNS Health Care
- Exchange
- ABL Nasdaq
- AVNS Nasdaq
- Market Cap
- ABL 639.8M
- AVNS 591.9M
- IPO Year
- ABL N/A
- AVNS N/A
- Fundamental
- Price
- ABL $5.97
- AVNS $11.41
- Analyst Decision
- ABL Strong Buy
- AVNS
- Analyst Count
- ABL 3
- AVNS 0
- Target Price
- ABL $12.83
- AVNS N/A
- AVG Volume (30 Days)
- ABL 971.0K
- AVNS 635.6K
- Earning Date
- ABL 11-06-2025
- AVNS 10-29-2025
- Dividend Yield
- ABL N/A
- AVNS N/A
- EPS Growth
- ABL N/A
- AVNS N/A
- EPS
- ABL N/A
- AVNS N/A
- Revenue
- ABL $161,724,466.00
- AVNS $692,500,000.00
- Revenue This Year
- ABL $79.57
- AVNS $0.25
- Revenue Next Year
- ABL $21.05
- AVNS $1.33
- P/E Ratio
- ABL N/A
- AVNS N/A
- Revenue Growth
- ABL 69.56
- AVNS 1.48
- 52 Week Low
- ABL $4.60
- AVNS $9.30
- 52 Week High
- ABL $10.30
- AVNS $23.68
- Technical
- Relative Strength Index (RSI)
- ABL 40.82
- AVNS 43.33
- Support Level
- ABL $5.64
- AVNS $11.31
- Resistance Level
- ABL $6.39
- AVNS $12.00
- Average True Range (ATR)
- ABL 0.28
- AVNS 0.42
- MACD
- ABL -0.03
- AVNS -0.07
- Stochastic Oscillator
- ABL 27.74
- AVNS 12.82
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.